(Date:11/9/2009)... Speaker Nancy Pelosi r...s in the Affordable Health Care for America Ac... and reduce Medicare Part D costs for people livin...urday by a vote of 220 to 215: ,, "Effective d...ty of life for thousands of Americans living with ...
(Date:11/9/2009)...d to transform our current campaign finance system... -- Members of Congress who noted "no" on health c...ceived $2.3 million more in campaign donations fro...in favor of the legislation to overhaul of the nat...leased by a coalition of campaign reform groups. ,...
(Date:11/9/2009)...ble in French . , , Montreal, November 9, 20...emale. In human bodies trillions of cells are coup... are composed. Yet these don,t come in twos, they...cause these complex cell networks are the backbone...ed for ways to splice cell clusters down to their ...
(Date:11/9/2009)... 2009 The first human embryonic stem cell treatme...shown to restore limb function in rats with neck s...he clinical trial to include people with cervical ...istration gave Geron Corp. of Menlo Park, Calif., ...viduals with thoracic spinal cord injuries, which ...
(Date:11/9/2009)...m risks, but not all agree , , MONDAY, N...aline solution might have soothing short-term bene... infections in the long run by stripping your nose... nose, we are removing the bad mucus but, unfortun...ntains the antimicrobial agents as well," said Dr....
Breaking Medicine News(10 mins):Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2Health News:UCI embryonic stem cell therapy restores walking ability in rats with neck injuries 2Health News:Sinus Rinses May Do More Harm Than Good 2Health News:Sinus Rinses May Do More Harm Than Good 3(Date:11/9/2009)..., POTOMAC FALLS, Va., Nov. 9 Tess...croarray-based applications, announces the launch ...sting of the mutations that underlie human heredit...tise in microarray-based resequencing with novel n...ysis software enables screening for all targeted m...
(Date:11/9/2009)..., PALO ALTO, Calif., Nov. 9 Women... it has changed its name to Viveve as it prepares ...in select U.S. markets. ,, "Viveve is a name th...focus on women,s sexual health," said Kerry Pope, ...ists for the sole purpose of helping women restore...
(Date:11/9/2009)..., VIRGINIA BEACH, Va., Nov. 9 Lif...ny, announces the launch of Vertigraft Cervical Bi..., Preservon® is a new, proprietary glycero...t bio-implants to be stored in a fully hydrated st...ed to freeze or freeze-dry bio-implants, doing awa...
Breaking Medicine Technology:TessArae Delivers Lower Cost Option to Genetic Testing Market 2Women's Sexual Health Company Changes Name in Preparation for Market Entry 2LifeNet Health Announces First Bio-Implant with New Preservation Technology 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 1CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 2CardioDynamics Shareholders Approve Merger Agreement with SonoSite 54251 3Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 1Astellas Named Elite Winner for Employee Engagement and Commitment in Chicagos 101 Best and Brightest Companies to Work For Competition 54247 2ParagonRx Sponsors Webinar on Demand By DSEC on Role of Drug Safety Officers 13507 1...16, 2007 /PRNewswire-FirstCall/ --,Genzyme Corp. a...Renvela(TM) (sevelamer carbonate) achieved its pri...ficant reduction in serum,phosphorus for hyperphos...are not on dialysis. , Patients treated with Renve...m-phosphorus product and in LDL cholesterol. The,d...
...ril 16, 2007 /PRNewswire-FirstCall/ --,Threshold P...esentations regarding its oncology pipeline, which...oxically Activated Prodrug,TH-302, and two resear...r program. The presentations will take place at th...ACR) annual meeting,being held April 14 - 18, 2007...
Other Medicine Technology:Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 2Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 3Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 2Threshold Pharmaceuticals Announces Multiple Presentations on,Oncology Pipeline at the 2007 American Association for Cancer,Research (AACR) Annual Meeting 3Ethicon Medium Clip (insert only)
Ethicon Medium Clip
High Sensitivity CRP
LabDAQ3 Laboratory Information System
Medicine Products: